Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Identification of New Genes Downregulated in Prostate Cancer and Investigation of Their Effects on Prognosis

(2013) Lokman Varisli   Genetic Testing and Molecular Biomarkers

Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer

(2013) Hsin-Yao Tang et al.   Journal of Proteomics

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

Myopathies associated with β-tropomyosin mutations

(2012) H. Tajsharghi et al.   NEUROMUSCULAR DISORDERS

RET is a potential tumor suppressor gene in colorectal cancer

(2012) Y Luo et al.   ONCOGENE

mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways

(2011) P. Gulhati et al.   CANCER RESEARCH

1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway

(2011) X. Pang et al.   CARCINOGENESIS

Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma

(2011) Andrew M. Kaz et al.   GENES CHROMOSOMES & CANCER

TOR kinase complexes and cell migration

(2011) Lunhua Liu et al.   JOURNAL OF CELL BIOLOGY

Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis

(2008) William M. Grady et al.   GASTROENTEROLOGY